Skip to main content
. 2024 Dec 28;14:31371. doi: 10.1038/s41598-024-82896-5

Table 3.

CT characteristics of patients with basaloid and non-basaloid SCCs.

Characteristic Basaloid (n = 39) Non-basaloid (n = 161) p value
Tumor size (mm)a 34.987 ± 18.1393 38.018 ± 18.1098 0.350
Pre-contrast CT value (HU)a 29.194 ± 12.2769 26.771 ± 11.9599 0.282
Post-contrast CT value (HU)a 59.308 ± 20.1206 57.067 ± 19.6877 0.526
Net enhancement value (HU)a 29.702 ± 17.0234 29.850 ± 17.1349 0.963
Margin 0.739
Smooth 0 (0) 2 (1.2)
Spiculated/Lobulated 36 (92.3) 144 (89.4)
Not assessable 3 (7.7) 15 (9.3)
Shape 0.839
Round 0 (0) 1 (0.6)
Lobular/Irregular 36 (92.3) 145 (90.1)
Not assessable 3 (7.7) 15 (9.3)
Distribution 0.256
Central 25 (64.1) 87 (54.0)
Peripheral 14 (35.9) 74 (46.0)
Endobronchial tumor growth 0.028
No 21 (53.8) 116 (72.0)
Yes 18 (46.2) 45 (28.0)
Cavitation 0.005
No 39 (100) 136 (84.5)
Yes 0 (0) 25 (15.5)
Internal profuse necrosis 0.022
No 35 (89.7) 115 (71.4)
Yes 4 (10.3) 46 (28.6)
Calcification 0.058
No 33 (84.6) 151 (93.8)
Yes 6 (15.4) 10 (6.2)
Air bronchogram 0.011
No 32 (82.1) 152 (94.4)
Yes 7 (17.9) 9 (5.6)
Pleural tagging 0.668
No 26 (66.7) 113 (70.2)
Yes 13 (33.3) 48 (29.8)
Fissural / Pleural retraction 0.907
No 33 (84.6) 135 (8.9)
Yes 6 (15.4) 26 (16.1)
Pleural Effusion 0.098
No 37 (94.9) 160 (99.4)
Yes 2 (5.1) 1 (0.6)
Pericardial effusion
No 39 (100) 161 (100)
Yes 0 (0) 0 (0)
Obstructive pneumonia or atelectasis 0.028
No 23 (59.0) 123 (76.4)
Yes 16 (41.0) 38 (23.6)
Emphysema 0.208
No 24 (61.5) 81 (50.3)
Yes 15 (38.5) 80 (49.7)

Unless otherwise indicated, data are given as number of patients with percentages in parentheses.

a Data are given as mean ± standard deviation. A p value < 0.05 was considered to be significant.